ACME UNITED REPORTS SECOND QUARTER 2026 NET SALES INCREASE OF 16% AND NET INCOME INCREASE OF 6%
ACME UNITED CORP (ACU) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 acu-ex99_1.htm EX-99.1 EX-99.1 Ex 99.1 ACME UNITED CORPORATION NEWS RELEASE CONTACT: Paul G. Driscoll Acme United Corporation 1 Waterview Drive Shelton, CT 06484 Phone: (203) 254-6060 FOR IMMEDIATE RELEASE July 23, 2026 ACME UNITED REPORTS SECOND QUARTER 2026 NET SALES
How this was made
The 30-second read
Why it matters
Traders can update near-term expectations for revenue growth, gross margin trajectory, and financing/capital structure following the new $65M syndicated credit facility and the acquisition-related cash flow profile.
Market read
Fresh quarterly numbers plus explicit guidance on tariff-related margin pressure and acquisition integration progress create actionable inputs for earnings-model updates.
What to watch
My Medic is seasonal with profitability concentrated in Q4, so second-quarter earnings may understate the acquisition’s longer-term earnings power; also, gross margin improvement is partly influenced by acquisition mix.
Background
Acme United filed an 8-K with its Q2 2026 results, including performance by segment and commentary on the My Medic acquisition and tariff impacts.
Ticker impact
Acme United reported Q2 2026 net sales of $62.7M (+16%) and net income of $5.1M (+6%), plus margin pressure from elevated tariffs.
Near-term bias modestly positive on revenue and income growth, but tempered by management’s expectation that tariff-driven margin pressure continues.
This is a primary 8-K earnings release with multiple quantified datapoints (sales, income, margins) and a specific stated expectation about tariff impacts in coming quarters, which can drive revisions to near-term margin outlook.
Market effects
Signals ongoing demand strength in safety and cutting tools, but highlights tariff-driven gross margin sensitivity for consumer and industrial product suppliers.
European sales growth (24% in USD, 19% local currency) suggests strength outside the U.S., potentially supporting regional distributor sentiment.
Tariff pass-through and sourcing cost dynamics are relevant to global supply chains for similar branded safety and cutting product companies.
Counterpoint
Despite revenue and income growth, the six-month net income declined 6% and management flags continued tariff pressure, which could limit multiple expansion.
Key entities
- companyAcme United Corporation
Reported Q2 2026 results, discussed tariff-driven margin pressure, and provided updates on the My Medic acquisition and financing.
- business_unitMy Medic
Direct-to-consumer tactical, trauma, and emergency response products acquired in January 2026; seasonal profitability expected to be concentrated in Q4.
- lenderHSBC Bank USA, N.A. and City National Bank
Part of the new $65M syndicated credit facility entered July 15, 2026.
